Key result
Heart rate variability biofeedback is a potential add-on therapy to counteract cardiac dysautonomia in patients with depression, though larger confirmatory trials are currently lacking.
Why the study?
Depression is associated with cardiac dysautonomia, and while psychopharmacological treatment improves affective symptoms, its effect on dysautonomia is limited and larger confirmatory trials of heart rate variability biofeedback are lacking.
Does heart rate variability biofeedback improve cardiac dysautonomia in patients suffering from depression?
Population
Patients suffering from depression
Design
Literature review
Authors
Loading...
Should not yet change practice for dysautonomia in depression; leaves open efficacy pending larger confirmatory trials.
Does heart rate variability biofeedback improve cardiac dysautonomia in patients suffering from depression?
HRV biofeedback is a promising non-invasive technique to counteract cardiac dysautonomia in depression, though larger confirmatory trials are needed.
Pintér et al. (2019) conducted a review in Depression. Heart rate variability (HRV) biofeedback was evaluated. Heart rate variability biofeedback is a potential add-on therapy to counteract cardiac dysautonomia in patients with depression, though larger confirmatory trials are currently lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: